Dosidal · Belgium

Hibiwash 40 mg/ml

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketBelgium
Recordbe:presentation:cti:662056-01 (version 1)
Levelpresentation
Pack codebe-cnk (Belgian national): 4928362
Identifiersbe-cti-extended: 662056-01
be-cnk: 4928362
be-authorisation: BE662056
Source authorityFAMHP
Read date2026-11-15T03:58:09Z
authorisation statusamp_status: AUTHORIZED
ampp_status: AUTHORIZED
commercialised_now: False
lifecycle: current
period_from: 2025-05-01
supply_problem_now: False
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
controlled status
state: unknown
identityamp_code: SAM662055-00
atc: D08AC02
authorisation_number: BE662056
cti_extended: 662056-01
form: Cutaneous solution
holder: Mölnlycke Health Care AB SE
medicine_type: ALLOPATHIC
name: Hibiwash 40 mg/ml
pack: 5 l
parallel_circuit: 0
parallel_import: False
substances: strength: 40.0000 mg/mL
substance: Chlorhexidine Digluconate
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
pack product codecnk_public: 4928362
fmd_in_scope: False
note: no FMD product code in SAM for this pack: the maker's GTIN is not published
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
prescription classas_published: Free delivery - Art 6, §1 bis, 1st paragraph, 2nd indent Law 25/03/1964 + Art 65, §3 Royal Decree 14/12/2006
class: non_prescription
delivery_modus: FD
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
4a6fy3vAt-pwZchsC3e_XjqVceQ-GO3fLGOUTSo23AMKAsSzkgd0-pN4G4MiHpTABNrGYEkKo2-3zIrn2QNrOw
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/be:presentation:cti:662056-01 · Same medicine in other markets · Dosidal